Related Experiment Videos
Prognostic factors in pleuro-pulmonary blastoma
Paolo Indolfi1, Gianni Bisogno, Fiorina Casale
1Pediatric Oncology Service Second University of Naples, Italy. paolo.indolfi@unina2.it
Pediatric Blood & Cancer
|April 19, 2006
Summary
Pleuropulmonary blastoma (PPB) is aggressive. Achieving total tumor resection improves prognosis, while extrapulmonary spread at diagnosis worsens outcomes for pediatric patients.
Area of Science:
- Pediatric Oncology
- Thoracic Surgery
- Cancer Prognostics
Background:
- Pleuropulmonary blastoma (PPB) is a rare and aggressive pediatric thoracic malignancy.
- Understanding prognostic factors is crucial for optimizing treatment strategies in children with PPB.
Purpose of the Study:
- To identify and evaluate key prognostic factors influencing outcomes in a cohort of children diagnosed with pleuropulmonary blastoma (PPB).
Main Methods:
- Retrospective analysis of clinicopathological data, treatment, and outcomes from 22 pediatric PPB cases across 13 Italian centers.
- Correlation of clinical, surgical, and pathological findings with patient outcomes using statistical methods.
Main Results:
- Median age of patients was 30.5 months; median follow-up was 22 months.
- Total tumor resection at any point during treatment significantly improved prognosis (P=0.01).
- Extrapulmonary involvement at diagnosis was associated with a significantly worse prognosis (P=0.01).
Conclusions:
- Pleuropulmonary blastoma (PPB) is an aggressive neoplasm requiring effective management.
- Complete surgical resection is a critical factor for improving survival in pediatric PPB patients.
- Early diagnosis and avoidance of extrapulmonary spread are vital for better patient outcomes.
